Gleevec, Nexavar cases put India’s IP laws to test
The debate on patents vs patients remains on the boil, with the Bayer/ Nexavar and Novartis/ Gleevec cases keeping the issue live.…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.